Thomas Kühr

Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.

Oliver Bechter, W Eisterer, Georg Pall et al. · PubMed · 1998 · 126 citations

Medicine, Molecular Biology, Oncology +14

CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia

Oliver Bechter, Wolfgang Eisterer, Margit Dlaska et al. · Experimental Hematology · 2002 · 72 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

p53-Binding Protein 1 Is Fused to the Platelet-Derived Growth Factor Receptor β in a Patient with a t(5;15)(q33;q22) and an Imatinib-Responsive Eosinophilic Myeloproliferative Disorder

Francis Grand, Sonja Burgstaller, Thomas Kühr et al. · Cancer Research · 2004 · 72 citations

Life Sciences, Molecular Biology, Molecular Genetics +16

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 47 citations

Medicine, Oncology, Pharmacotherapy +12

Thrombotic Microangiopathy with Renal Failure in Two Patients Undergoing Gemcitabine Chemotherapy

Karl Lhotta, Thomas Kühr, Hans J. Rumpelt et al. · American Journal of Nephrology · 1999 · 33 citations

Medicine, Hematology, Oncology +13